Diagnostic accuracy of procalcitonin and interleukin-6 values for predicting bacteremia and clinical sepsis in febrile neutropenic children with cancer

被引：51
作者：
Kitanovski, L
Jazbec, J
Hojker, S
Gubina, M
Derganc, M
机构：
[1] Univ Med Ctr Ljubljana, Dept Pediat, Div Hematol & Oncol, Ljubljana 1000, Slovenia
[2] Univ Med Ctr Ljubljana, Dept Nucl Med, Ljubljana, Slovenia
[3] Univ Ljubljana, Sch Med, Dept Microbiol & Immunol, Ljubljana, Slovenia
[4] Univ Med Ctr Ljubljana, Dept Pediat Surg & Intens Care, Ljubljana, Slovenia
来源：
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES | 2006年 / 25卷 / 06期
关键词：
D O I：
10.1007/s10096-006-0143-x
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
[No abstract available]
引用
收藏
页码：413 / 415
页数：3
相关论文
共 12 条
[1]   Procalcitonin levels in plasma in oncohaematologic patients with and without bacterial infections [J].
Ciaccio, M ;
Fugardi, G ;
Titone, L ;
Romano, A ;
Giordano, S ;
Bivona, G ;
Scarlata, F ;
Vocca, L ;
Di Gangi, M .
CLINICA CHIMICA ACTA, 2004, 340 (1-2) :149-152
[2]   Procalcitonin: A Diagnostic Marker of Bacterial Infection in Neutropenic Cancer Patients with Fever? [J].
Infection, 2000, 28 (6) :398-400
[3]   An analysis of interleukin-8, interleukin-6 and C-reactive protein serum concentrations to predict fever, gram-negative bacteremia and complicated infection in neutropenic cancer patients [J].
Engel, A ;
Mack, E ;
Kern, P ;
Kern, WV .
INFECTION, 1998, 26 (04) :213-221
[4]   Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor II [J].
Fleischhack, G ;
Kambeck, I ;
Cipic, D ;
Hasan, C ;
Bode, U .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 111 (04) :1093-1102
[5]   Potential use of procalcitonin as a diagnostic criterion in febrile neutropenia:: experience from a multicentre study [J].
Giamarellou, H ;
Giamarellos-Bourboulis, EJ ;
Repoussis, P ;
Galani, L ;
Anagnostopoulos, N ;
Grecka, P ;
Lubos, D ;
Aoun, M ;
Athanassiou, K ;
Bouza, E ;
Devigili, E ;
Krçmery, V ;
Menichetti, F ;
Panaretou, E ;
Papageorgiou, E ;
Plachouras, D .
CLINICAL MICROBIOLOGY AND INFECTION, 2004, 10 (07) :628-633
[6]   A METHOD OF COMPARING THE AREAS UNDER RECEIVER OPERATING CHARACTERISTIC CURVES DERIVED FROM THE SAME CASES [J].
HANLEY, JA ;
MCNEIL, BJ .
RADIOLOGY, 1983, 148 (03) :839-843
[7]   Assessment of procalcitonin as a diagnostic and prognostic marker in patients with solid tumors and febrile neutropenia [J].
Jimeno, A ;
Garcia-Velasco, A ;
del Val, O ;
González-Billalabeitia, E ;
Hernando, S ;
Hernández, R ;
Sánchez-Muñoz, A ;
López-Martín, A ;
Durán, I ;
Robles, L ;
Cortés-Funes, H ;
Paz-Ares, L .
CANCER, 2004, 100 (11) :2462-2469
[8]   Use of inflammatory markers for early detection of bacteraemia in patients with febrile neutropenia [J].
Persson, L ;
Engervall, P ;
Magnuson, A ;
Vikerfors, T ;
Söderquist, B ;
Hansson, LO ;
Tidefelt, U .
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES, 2004, 36 (05) :365-371
[9]   THE DESIGN, ANALYSIS, AND REPORTING OF CLINICAL-TRIALS ON THE EMPIRICAL ANTIBIOTIC MANAGEMENT OF THE NEUTROPENIC PATIENT - REPORT OF A CONSENSUS PANEL [J].
PIZZO, PA ;
ARMSTRONG, D ;
BODEY, G ;
DEPAUW, B ;
FELD, R ;
GLAUSER, M ;
GAYA, H ;
KARP, J ;
KLASTERSKY, J ;
TODESCHINI, G ;
VERHOEF, J ;
WADE, J ;
YOUNG, LS ;
REMINGTON, J .
JOURNAL OF INFECTIOUS DISEASES, 1990, 161 (03) :397-401
[10]   C-REACTIVE PROTEIN - A VALUABLE AID FOR THE MANAGEMENT OF FEBRILE CHILDREN WITH CANCER AND NEUTROPENIA [J].
SANTOLAYA, ME ;
COFRE, J ;
BERESI, V .
CLINICAL INFECTIOUS DISEASES, 1994, 18 (04) :589-595
12